DK166806B1 - Anvendelse af plantepollenekstrakter til fremstilling af farmaceutiske, tumorcellevaeksthaemmende praeparater - Google Patents

Anvendelse af plantepollenekstrakter til fremstilling af farmaceutiske, tumorcellevaeksthaemmende praeparater Download PDF

Info

Publication number: DK166806B1
Authority: DK; Denmark
Prior art keywords: pollen; cells; amino acids; peptides; extracts
Prior art date: 1985-09-20

Application number

DK445686A

Other languages

Danish (da)

English (en)

Other versions

DK445686A (da

DK445686D0 (da

Inventor

Ari Lewenstein

Fouad K Habib

Original Assignee

Cernitin Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1985-09-20

Filing date

1986-09-17

Publication date

1993-07-19

1986-09-17 Application filed by Cernitin Sa filed Critical Cernitin Sa

1986-09-17 Publication of DK445686D0 publication Critical patent/DK445686D0/da

1987-03-21 Publication of DK445686A publication Critical patent/DK445686A/da

1993-07-19 Application granted granted Critical

1993-07-19 Publication of DK166806B1 publication Critical patent/DK166806B1/da

Links

239000000284 extract Substances 0.000 title claims abstract description 83
238000002360 preparation method Methods 0.000 title claims description 18
230000004565 tumor cell growth Effects 0.000 title description 2
210000004027 cell Anatomy 0.000 claims abstract description 94
150000001413 amino acids Chemical class 0.000 claims abstract description 29
108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 27
102000004196 processed proteins & peptides Human genes 0.000 claims abstract description 24
206010028980 Neoplasm Diseases 0.000 claims abstract description 21
102000004169 proteins and genes Human genes 0.000 claims abstract description 20
108090000623 proteins and genes Proteins 0.000 claims abstract description 20
239000000126 substance Substances 0.000 claims abstract description 20
208000032839 leukemia Diseases 0.000 claims abstract description 19
201000011510 cancer Diseases 0.000 claims abstract description 16
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 16
241000282414 Homo sapiens Species 0.000 claims abstract description 15
210000004881 tumor cell Anatomy 0.000 claims abstract description 13
230000004060 metabolic process Effects 0.000 claims abstract description 11
230000012010 growth Effects 0.000 claims abstract description 10
235000013343 vitamin Nutrition 0.000 claims abstract description 4
CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 20
239000000047 product Substances 0.000 claims description 18
238000004113 cell culture Methods 0.000 claims description 13
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 11
239000000203 mixture Substances 0.000 claims description 11
239000008194 pharmaceutical composition Substances 0.000 claims description 11
WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 claims description 9
230000004614 tumor growth Effects 0.000 claims description 9
239000013543 active substance Substances 0.000 claims description 8
239000003960 organic solvent Substances 0.000 claims description 7
239000002244 precipitate Substances 0.000 claims description 7
239000012736 aqueous medium Substances 0.000 claims description 6
239000002904 solvent Substances 0.000 claims description 6
206010060862 Prostate cancer Diseases 0.000 claims description 5
208000000236 Prostatic Neoplasms Diseases 0.000 claims description 5
244000005700 microbiome Species 0.000 claims description 5
239000005711 Benzoic acid Substances 0.000 claims description 4
239000007864 aqueous solution Substances 0.000 claims description 4
235000010233 benzoic acid Nutrition 0.000 claims description 4
230000004936 stimulating effect Effects 0.000 claims description 4
208000024313 Testicular Neoplasms Diseases 0.000 claims description 3
206010057644 Testis cancer Diseases 0.000 claims description 3
230000009471 action Effects 0.000 claims description 3
230000003247 decreasing effect Effects 0.000 claims description 3
150000002576 ketones Chemical class 0.000 claims description 3
150000007524 organic acids Chemical class 0.000 claims description 3
201000003120 testicular cancer Diseases 0.000 claims description 3
239000011782 vitamin Substances 0.000 claims description 3
229930003231 vitamin Natural products 0.000 claims description 3
229940088594 vitamin Drugs 0.000 claims description 3
206010005003 Bladder cancer Diseases 0.000 claims description 2
206010006187 Breast cancer Diseases 0.000 claims description 2
208000026310 Breast neoplasm Diseases 0.000 claims description 2
206010023825 Laryngeal cancer Diseases 0.000 claims description 2
229920005654 Sephadex Polymers 0.000 claims description 2
239000012507 Sephadex™ Substances 0.000 claims description 2
208000007097 Urinary Bladder Neoplasms Diseases 0.000 claims description 2
230000005907 cancer growth Effects 0.000 claims description 2
206010023841 laryngeal neoplasm Diseases 0.000 claims description 2
201000007270 liver cancer Diseases 0.000 claims description 2
208000014018 liver neoplasm Diseases 0.000 claims description 2
FEMOMIGRRWSMCU-UHFFFAOYSA-N ninhydrin Chemical compound C1=CC=C2C(=O)C(O)(O)C(=O)C2=C1 FEMOMIGRRWSMCU-UHFFFAOYSA-N 0.000 claims description 2
201000005112 urinary bladder cancer Diseases 0.000 claims description 2
239000004215 Carbon black (E152) Substances 0.000 claims 1
239000002274 desiccant Substances 0.000 claims 1
238000001035 drying Methods 0.000 claims 1
238000001704 evaporation Methods 0.000 claims 1
230000008020 evaporation Effects 0.000 claims 1
229930195733 hydrocarbon Natural products 0.000 claims 1
150000002430 hydrocarbons Chemical class 0.000 claims 1
238000005192 partition Methods 0.000 claims 1
238000001556 precipitation Methods 0.000 claims 1
150000001720 carbohydrates Chemical class 0.000 abstract description 4
235000014633 carbohydrates Nutrition 0.000 abstract description 4
239000000470 constituent Substances 0.000 abstract description 4
238000000605 extraction Methods 0.000 abstract description 3
229910052500 inorganic mineral Inorganic materials 0.000 abstract description 3
239000011707 mineral Substances 0.000 abstract description 3
239000000825 pharmaceutical preparation Substances 0.000 abstract description 2
241001465754 Metazoa Species 0.000 abstract 1
239000004480 active ingredient Substances 0.000 abstract 1
241000196324 Embryophyta Species 0.000 description 20
238000000034 method Methods 0.000 description 18
230000008569 process Effects 0.000 description 8
241000235395 Mucor Species 0.000 description 5
229950006790 adenosine phosphate Drugs 0.000 description 5
238000000855 fermentation Methods 0.000 description 5
230000004151 fermentation Effects 0.000 description 5
238000004519 manufacturing process Methods 0.000 description 5
239000000243 solution Substances 0.000 description 5
IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
239000003795 chemical substances by application Substances 0.000 description 4
235000001674 Agaricus brunnescens Nutrition 0.000 description 3
241000233866 Fungi Species 0.000 description 3
238000002474 experimental method Methods 0.000 description 3
230000009036 growth inhibition Effects 0.000 description 3
239000000463 material Substances 0.000 description 3
239000000843 powder Substances 0.000 description 3
206010020751 Hypersensitivity Diseases 0.000 description 2
235000007238 Secale cereale Nutrition 0.000 description 2
230000002009 allergenic effect Effects 0.000 description 2
230000007815 allergy Effects 0.000 description 2
239000006286 aqueous extract Substances 0.000 description 2
230000015556 catabolic process Effects 0.000 description 2
238000002512 chemotherapy Methods 0.000 description 2
239000000824 cytostatic agent Substances 0.000 description 2
230000006735 deficit Effects 0.000 description 2
230000000694 effects Effects 0.000 description 2
239000000706 filtrate Substances 0.000 description 2
238000001914 filtration Methods 0.000 description 2
238000001502 gel electrophoresis Methods 0.000 description 2
230000009422 growth inhibiting effect Effects 0.000 description 2
230000002147 killing effect Effects 0.000 description 2
210000000265 leukocyte Anatomy 0.000 description 2
210000002332 leydig cell Anatomy 0.000 description 2
239000007788 liquid Substances 0.000 description 2
239000002609 medium Substances 0.000 description 2
229910052757 nitrogen Inorganic materials 0.000 description 2
210000005267 prostate cell Anatomy 0.000 description 2
238000010186 staining Methods 0.000 description 2
230000000638 stimulation Effects 0.000 description 2
239000000758 substrate Substances 0.000 description 2
240000000724 Berberis vulgaris Species 0.000 description 1
235000016068 Berberis vulgaris Nutrition 0.000 description 1
208000010392 Bone Fractures Diseases 0.000 description 1
IVOMOUWHDPKRLL-KQYNXXCUSA-N Cyclic adenosine monophosphate Chemical compound C([C@H]1O2)OP(O)(=O)O[C@H]1[C@@H](O)[C@@H]2N1C(N=CN=C2N)=C2N=C1 IVOMOUWHDPKRLL-KQYNXXCUSA-N 0.000 description 1
FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
238000012404 In vitro experiment Methods 0.000 description 1
241001117491 Mucor brunneogriseus Species 0.000 description 1
241001169397 Mucor corticola Species 0.000 description 1
241000114093 Mucor flavus Species 0.000 description 1
241000907556 Mucor hiemalis Species 0.000 description 1
241000025769 Mucor luteus Species 0.000 description 1
241001149951 Mucor mucedo Species 0.000 description 1
PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
229910019142 PO4 Inorganic materials 0.000 description 1
241000209056 Secale Species 0.000 description 1
244000082988 Secale cereale Species 0.000 description 1
GLNADSQYFUSGOU-GPTZEZBUSA-J Trypan blue Chemical compound [Na+].[Na+].[Na+].[Na+].C1=C(S([O-])(=O)=O)C=C2C=C(S([O-])(=O)=O)C(/N=N/C3=CC=C(C=C3C)C=3C=C(C(=CC=3)\N=N\C=3C(=CC4=CC(=CC(N)=C4C=3O)S([O-])(=O)=O)S([O-])(=O)=O)C)=C(O)C2=C1N GLNADSQYFUSGOU-GPTZEZBUSA-J 0.000 description 1
229930003537 Vitamin B3 Natural products 0.000 description 1
238000009825 accumulation Methods 0.000 description 1
230000032683 aging Effects 0.000 description 1
150000001298 alcohols Chemical class 0.000 description 1
150000007933 aliphatic carboxylic acids Chemical class 0.000 description 1
208000026935 allergic disease Diseases 0.000 description 1
WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
230000001093 anti-cancer Effects 0.000 description 1
229940121363 anti-inflammatory agent Drugs 0.000 description 1
239000002260 anti-inflammatory agent Substances 0.000 description 1
239000003125 aqueous solvent Substances 0.000 description 1
PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 1
PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 1
125000003118 aryl group Chemical group 0.000 description 1
230000008901 benefit Effects 0.000 description 1
SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
QKSKPIVNLNLAAV-UHFFFAOYSA-N bis(2-chloroethyl) sulfide Chemical compound ClCCSCCCl QKSKPIVNLNLAAV-UHFFFAOYSA-N 0.000 description 1
210000000481 breast Anatomy 0.000 description 1
230000019522 cellular metabolic process Effects 0.000 description 1
230000000973 chemotherapeutic effect Effects 0.000 description 1
238000004440 column chromatography Methods 0.000 description 1
230000001085 cytostatic effect Effects 0.000 description 1
238000006731 degradation reaction Methods 0.000 description 1
239000012153 distilled water Substances 0.000 description 1
238000001962 electrophoresis Methods 0.000 description 1
230000001747 exhibiting effect Effects 0.000 description 1
229930182830 galactose Natural products 0.000 description 1
239000008103 glucose Substances 0.000 description 1
125000003563 glycoside group Chemical group 0.000 description 1
230000035876 healing Effects 0.000 description 1
210000005260 human cell Anatomy 0.000 description 1
239000003112 inhibitor Substances 0.000 description 1
230000002401 inhibitory effect Effects 0.000 description 1
230000005764 inhibitory process Effects 0.000 description 1
201000004962 larynx cancer Diseases 0.000 description 1
235000010355 mannitol Nutrition 0.000 description 1
230000011278 mitosis Effects 0.000 description 1
239000012452 mother liquor Substances 0.000 description 1
230000017095 negative regulation of cell growth Effects 0.000 description 1
230000017066 negative regulation of growth Effects 0.000 description 1
229960003512 nicotinic acid Drugs 0.000 description 1
DFPAKSUCGFBDDF-UHFFFAOYSA-N nicotinic acid amide Natural products NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 1
239000000813 peptide hormone Substances 0.000 description 1
230000000144 pharmacologic effect Effects 0.000 description 1
239000010452 phosphate Substances 0.000 description 1
NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
230000002265 prevention Effects 0.000 description 1
230000001737 promoting effect Effects 0.000 description 1
208000017497 prostate disease Diseases 0.000 description 1
230000002829 reductive effect Effects 0.000 description 1
239000007787 solid Substances 0.000 description 1
238000000638 solvent extraction Methods 0.000 description 1
241000894007 species Species 0.000 description 1
239000007858 starting material Substances 0.000 description 1
238000003756 stirring Methods 0.000 description 1
238000005728 strengthening Methods 0.000 description 1
230000004083 survival effect Effects 0.000 description 1
231100000331 toxic Toxicity 0.000 description 1
230000002588 toxic effect Effects 0.000 description 1
230000001988 toxicity Effects 0.000 description 1
231100000419 toxicity Toxicity 0.000 description 1
235000019164 vitamin B2 Nutrition 0.000 description 1
239000011716 vitamin B2 Substances 0.000 description 1
235000019160 vitamin B3 Nutrition 0.000 description 1
239000011708 vitamin B3 Substances 0.000 description 1
230000029663 wound healing Effects 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Mycology (AREA)
Natural Medicines & Medicinal Plants (AREA)
Alternative & Traditional Medicine (AREA)
Biotechnology (AREA)
Botany (AREA)
Medical Informatics (AREA)
Medicinal Chemistry (AREA)
Microbiology (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicines Containing Plant Substances (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

DK445686A 1985-09-20 1986-09-17 Anvendelse af plantepollenekstrakter til fremstilling af farmaceutiske, tumorcellevaeksthaemmende praeparater DK166806B1 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
CH408985		1985-09-20
CH408985		1985-09-20

Publications (3)

Publication Number	Publication Date
DK445686D0 DK445686D0 (da)	1986-09-17
DK445686A DK445686A (da)	1987-03-21
DK166806B1 true DK166806B1 (da)	1993-07-19

Family

ID=4269616

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK445686A DK166806B1 (da)	1985-09-20	1986-09-17	Anvendelse af plantepollenekstrakter til fremstilling af farmaceutiske, tumorcellevaeksthaemmende praeparater

Country Status (5)

Country	Link
US (1)	US4952399A (fr)
EP (1)	EP0220453B1 (fr)
AT (1)	ATE74761T1 (fr)
DE (1)	DE3684868D1 (fr)
DK (1)	DK166806B1 (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20030148933A1 (en) *	1990-10-01	2003-08-07	Pharma Mar S.A.	Derivatives of dehydrodidemnin B
EP0757055B1 (fr) *	1995-06-30	1999-10-27	Cerbios-Pharma S.A.	Glycosides, produits de dégradation exempt de sucre, et dérivés de tels produits
US6440448B1 (en)	1998-03-16	2002-08-27	Joseph Intelisano	Food supplement/herbal composition for health enhancement
CN1423564A (zh) *	1999-11-15	2003-06-11	法马马有限公司	癌症的aplidine治疗
WO2004080421A2 (fr) *	2003-03-12	2004-09-23	Pharma Mar, S.A.	Traitement antitumoraux ameliores
FR2881649B1 (fr) *	2005-02-10	2007-04-06	Du Sert Patrice Percie	Procede d'extraction de pollen frais, extrait lipidique obtenu et applications associees
WO2006136871A1 (fr) *	2005-06-21	2006-12-28	Codex V S.R.L.	Utilisation d'extraits de pollen pour traiter des infections, des neoplasmes et pour equilibrer la reponse immunitaire
CN101389347B (zh) *	2006-02-28	2013-03-27	法马马有限公司	提高的抗肿瘤治疗
AU2008313627A1 (en) *	2007-10-19	2009-04-23	Pharma Mar, S.A.	Improved antitumoral treatments
US20110009335A1 (en) *	2008-03-07	2011-01-13	Pharma Mar, S.A.	Anticancer Treatments
HRP20231233T1 (hr)	2017-04-27	2024-01-19	Pharma Mar, S.A.	Antitumorski spojevi

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE1025574B (de) *	1955-02-10	1958-03-06	Jean D Albret S A R L Soc	Verfahren zur Herstellung von Koerperpflegemitteln, insbesondere Hautpflegemitteln
SE307063B (fr) *	1963-07-30	1968-12-16	Cernelle Ab
FR1575114A (fr) *	1968-07-24	1969-07-18
FR2142194A5 (en) *	1971-06-16	1973-01-26	Socibre	Allergen-free pollen extracts - stabilized by freeze-drying
CH663900A5 (de) *	1985-05-06	1988-01-29	Cernitin Sa	Pharmazeutisches praeparat zur prophylaktischen behandlung von allergien und verfahren zur herstellung dieses praeparates.

1986
- 1986-09-13 AT AT86112691T patent/ATE74761T1/de not_active IP Right Cessation
- 1986-09-13 DE DE8686112691T patent/DE3684868D1/de not_active Expired - Fee Related
- 1986-09-13 EP EP86112691A patent/EP0220453B1/fr not_active Expired - Lifetime
- 1986-09-17 DK DK445686A patent/DK166806B1/da not_active IP Right Cessation
1989
- 1989-07-20 US US07/384,054 patent/US4952399A/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
US4952399A (en)	1990-08-28
EP0220453A3 (en)	1988-03-23
DE3684868D1 (de)	1992-05-21
ATE74761T1 (de)	1992-05-15
DK445686A (da)	1987-03-21
EP0220453B1 (fr)	1992-04-15
EP0220453A2 (fr)	1987-05-06
DK445686D0 (da)	1986-09-17

Legal Events

Date	Code	Title
1992-11-30	AHS	Application shelved for other reasons than non-payment
1993-07-19	B1	Patent granted (law 1993)
2000-05-15	PBP	Patent lapsed

Publication	Publication Date	Title
DK166806B1 (da)	1993-07-19	Anvendelse af plantepollenekstrakter til fremstilling af farmaceutiske, tumorcellevaeksthaemmende praeparater
EP0030812B1 (fr)	1984-03-14	Procédé de préparation de composés inducteurs d'interféron et inducteurs d'interféron
KR101385191B1 (ko)	2014-04-21	치커리 추출물의 근육 손상 예방, 치료 또는 개선을 위한 용도
EP0035102A1 (fr)	1981-09-09	Oligopeptide isolable à partir de globules blancs sains ou de granulocytes, inhibant sélectivement la croissance ou l'accroissement respectivement de cellules myéloides normales et leucémiques, procédé pour sa préparation et médicaments le contenant
CN117503661B (zh)	2024-05-07	刺梨提取物的制备方法及其冻干粉在化妆品中的应用
US3394120A (en)	1968-07-23	Process of extracting protein from mistletoe and resultant product
EP0027514B1 (fr)	1983-08-31	Substance antitumorale et sa production
SU871721A3 (ru)	1981-10-07	Способ получени биологически активного вещества,обладающего способностью усиливать секрецию инсулина и улучшать глюкозную толерантность
CN118620098A (zh)	2024-09-10	一种刺梨多糖用于制备抗血管钙化的药物的用途
Hassan et al.	2020	Antileishmanial effect of berberine and extracts of Berberis vulgaris on the growth of leishmanial species
CN101708202B (zh)	2012-03-21	一种抑制血管舒张的药物
DE19543628A1 (de)	1997-05-28	Humanes, im Blut zirkulierendes Peptid mit insulinotroper Wirkung (GCAP-II-(89-112), (Guanylyl Cyclase C Aktivierendes Peptid II) und seine GCAP-Analoga, insbesondere das GCAP-I-(99-115), seine Anwendung als pharmakologischer Wirkstoff und Benutzung seines Wirkungsprinzipes zur Bereitstellung neuer GC-C-abhängiger insulinotroper Wirkstoffe
CN103285000B (zh)	2015-01-07	瘤果黑种草籽中具有骨架类型ⅰ和ⅱ生物碱的用途
RU2236244C2 (ru)	2004-09-20	Иммунотропный препарат "витулин в"
RU2794783C1 (ru)	2023-04-25	Применение спиртового экстракта березового гриба чага в качестве ростстимулирующего средства для томатов
EP0934746A1 (fr)	1999-08-11	Substance permettant de traiter des affections oncologiques et consistant en des extraits aqueux de matieres premieres naturelles, et procede de production de cette substance
RU2236247C2 (ru)	2004-09-20	Иммунотропный препарат "витулин а"
JP6969041B2 (ja)	2021-11-24	血管内皮型一酸化窒素合成酵素産生促進剤及び経口用組成物
US2541676A (en)	1951-02-13	Thromboplastic preparation
RU2241476C2 (ru)	2004-12-10	Иммунотропный препарат "витулин д"
CN118177372A (zh)	2024-06-14	一种抗蛋白羰基化组合物及其应用
PS et al.	2024	Phytochemical and Pharmacological Studies of Different Extracts of Stem Bark and Leaf of Flueggea leucopyrus Willd.
Couch	1943	Rutin for the capillaries
RO122244B1 (ro)	2009-03-30	Procedeu de obţinere a acidului oleanolic în stare pură, din herba viscum album
CN120349956A (zh)	2025-07-22	一种密度梯度离心联合排阻色谱提取植物外泌体的方法